<!DOCTYPE html>
<html lang="en">
    <head>
        <meta name="DC.IDENTIFIER" content="http://dx.doi.org/10.17917/YPTH-N396" scheme="DCTERMS.UI"><title>caNanoLab DOI Landing page</title>
        <style>
            h1 { text-align: center;}
            h2 { text-align: left;}
            table { border: 1px solid #dddddd; text-align: left; padding: 8px }
            td, th { border: 1px solid #dddddd; text-align: left; padding: 8px }
            tr:nth-child(even) { background-color: #dddddd }
        </style>
    </head><body><img src="./assets/images/crdc-logo.svg" alt="CRDC General Commons Logo"><h1> caNanoLab DOI </h1><hr><p><b>Protocol Type:</b> in vitro assay</p><p><b>Protocol Name:</b> NCL Method GTA-12: Autophagic Dysfunction in LLC-PK1 Cells</p><p><b>Protocol Abbreviation:</b> GTA-12</p><p><b>Protocol Version:</b> 1.1<hr><p><b>DOI:</b> <a href = http://dx.doi.org/10.17917/YPTH-N396>http://dx.doi.org/10.17917/YPTH-N396</a></p><p><b>Protocol File:</b> protocols/20240410_18-43-18-609_NCL_Method_GTA-12.pdf<p><b>File Title:</b> GTA-12</p><p><b>Description:</b></b> Lysosomal dysfunction is recognized as a potential toxic mechanism for xenobiotics that can result in various pathological states.  There is concern that nanoparticles, in particular, may cause lysosomal pathologies, since they are likely to accumulate within lysosomes.  Lysosomal dysfunction could potentially result from nanoparticle biopersistance, or inhibition of lysosomal enzymes, such as inhibition of phospholipase resulting in phospholipidosis, or inhibition of lysosomal protein degradation resulting in lysosomal overload.  Nanoparticle exposure has also been shown to cause autophagic dysfunction, resulting in increased lysosomal mediated degradation of cellular organelles.  Common methods used to characterize autophagic dysfunction include direct morphological assessment via light and electron microscopy, in both cell culture and tissue samples, as well as use of lysosomal dyes.  The method detailed in this protocol utilizes the latter lysosomal dye staining method, as it is suited to high throughput screening.<hr><p><b>Resource Type:</b>  Protocol</p><p><b>Data Access:</b> <a href =https://general.datacommons.cancer.gov/#/data>https://general.datacommons.cancer.gov/#/data</a><p></body></html>